[go: up one dir, main page]

FI871039A0 - Foerfarande foer bestaemmande av endoglykosidasaktivitet. - Google Patents

Foerfarande foer bestaemmande av endoglykosidasaktivitet.

Info

Publication number
FI871039A0
FI871039A0 FI871039A FI871039A FI871039A0 FI 871039 A0 FI871039 A0 FI 871039A0 FI 871039 A FI871039 A FI 871039A FI 871039 A FI871039 A FI 871039A FI 871039 A0 FI871039 A0 FI 871039A0
Authority
FI
Finland
Prior art keywords
endoglykosidasaktivitet
bestaemmande
foerfarande foer
foerfarande
foer
Prior art date
Application number
FI871039A
Other languages
English (en)
Other versions
FI871039A (fi
Inventor
Garth L Nicolson
Motowo Nakajima
Tatsuro Irimura
Original Assignee
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas filed Critical Univ Texas
Publication of FI871039A0 publication Critical patent/FI871039A0/fi
Publication of FI871039A publication Critical patent/FI871039A/fi
Priority to FI924244A priority Critical patent/FI924244A/fi
Priority to FI924243A priority patent/FI924243A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01031—Beta-glucuronidase (3.2.1.31)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/5743—Specifically defined cancers of skin, e.g. melanoma
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57469—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving tumor associated glycolinkage, i.e. TAG
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/924—Hydrolases (3) acting on glycosyl compounds (3.2)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/38—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence, e.g. gluco- or galactomannans, Konjac gum, Locust bean gum or Guar gum
    • G01N2400/40—Glycosaminoglycans, i.e. GAG or mucopolysaccharides, e.g. chondroitin sulfate, dermatan sulfate, hyaluronic acid, heparin, heparan sulfate, and related sulfated polysaccharides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Optics & Photonics (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
FI871039A 1986-03-10 1987-03-10 Foerfarande foer bestaemmande av endoglykosidasaktivitet. FI871039A (fi)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FI924244A FI924244A (fi) 1986-03-10 1992-09-22 Foerfarande foer bestaemmande av endoglykosidasaktivitet
FI924243A FI924243A (fi) 1986-03-10 1992-09-22 Foerfarande foer bestaemmande av endoglykosidasaktivitet

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83989086A 1986-03-10 1986-03-10
US07/012,860 US4859581A (en) 1986-03-10 1987-02-20 Endoglycosidase assay

Publications (2)

Publication Number Publication Date
FI871039A0 true FI871039A0 (fi) 1987-03-10
FI871039A FI871039A (fi) 1987-09-11

Family

ID=26684096

Family Applications (1)

Application Number Title Priority Date Filing Date
FI871039A FI871039A (fi) 1986-03-10 1987-03-10 Foerfarande foer bestaemmande av endoglykosidasaktivitet.

Country Status (6)

Country Link
US (2) US4859581A (fi)
EP (1) EP0244932A3 (fi)
AU (1) AU609386B2 (fi)
DK (1) DK122087A (fi)
FI (1) FI871039A (fi)
NO (1) NO870977L (fi)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4883751A (en) * 1986-05-28 1989-11-28 New York University Specific immunoassay for heparin
CA1339812C (en) * 1988-02-19 1998-04-14 Tamami Koyama Filler for measuring enzyme activity, column packed with the filler, andmethod of measuring enzyme activity by using the column
GB8815975D0 (en) * 1988-07-05 1988-08-10 Procter & Gamble Method for evaluating detergent cellulases
WO1991002977A1 (en) * 1989-08-23 1991-03-07 Hadassah Medical Organization Wound healing preparations containing heparanase
EP0532695A1 (en) * 1990-05-31 1993-03-24 Board Of Regents, The University Of Texas System Immunochemical localization of heparanase in mouse and human melanomas
DE69129417T2 (de) * 1991-01-15 1998-11-05 Oy Biotie Therapies, Turku Nachweis des syndecangehalts in biologischen materialien, wie geweben und körperflüssigkeiten, zur anzeige der bösartigen umwandlung von zellen
EP0639227A1 (en) * 1991-05-07 1995-02-22 Oxford Glycosciences (Uk) Limited Sequencing of oligosaccharides
JP3199405B2 (ja) * 1991-08-30 2001-08-20 生化学工業株式会社 肝細胞球状集塊化剤及び球状集塊化肝細胞の製造方法
DE4217474A1 (de) * 1992-05-27 1993-12-02 Boehringer Mannheim Gmbh Verfahren und Mittel zur Bestimmung eines Analyts
AU721069B2 (en) * 1993-04-14 2000-06-22 Litmus Concepts, Inc. Reporter enzyme release technology: methods of assaying for the presence of aspartic proteases and other hydrolytic enzyme activities
CA2160262C (en) * 1993-04-14 2002-03-26 Paul J. Lawrence Reporter enzyme release technology: methods of assaying for the presence of aspartic proteases and other hydrolytic enzyme activities
US5416003A (en) * 1993-04-14 1995-05-16 Litmus Concepts, Inc. Reporter enzyme release technology: methods of assaying for the presence of aspartic proteases and other hydrolytic enzyme activities
AU7205894A (en) * 1993-06-08 1995-01-03 Neogenix, Inc. Purified natural and synthetic compounds for the treatment of osteoarthritis
US5753445A (en) * 1994-04-26 1998-05-19 The Mount Sinai Medical Center Of The City University Of New York Test for the detection of anti-heparin antibodies
US6228998B1 (en) 1994-07-22 2001-05-08 Seikagaku Kogyo Kabushiki Kaisha Amino spacered glycosaminoglycan derivatives and their use in copolymerization with acrylamide
EP0848613A1 (en) * 1995-09-05 1998-06-24 Cambridge Neuroscience, Inc. Analogs for specific oligosaccharide-neuregulin interactions and uses thereof
DE19547684A1 (de) 1995-12-20 1997-06-26 Philips Patentverwaltung Verfahren und Anordnung zum kontaktlosen Übertragen
IL127043A0 (en) * 1996-05-14 1999-09-22 Univ Manitoba Solid-phase activity assay for biologically active substance
AUPN991796A0 (en) * 1996-05-17 1996-06-13 Women's And Children's Hospital Early detection of lysosomal storage disorders
TW565614B (en) * 1996-07-18 2003-12-11 Univ Australian Detection of mammalian heparanase activity and purification of mammalian heparanase
US6190875B1 (en) * 1997-09-02 2001-02-20 Insight Strategy & Marketing Ltd. Method of screening for potential anti-metastatic and anti-inflammatory agents using mammalian heparanase as a probe
US20010006630A1 (en) * 1997-09-02 2001-07-05 Oron Yacoby-Zeevi Introducing a biological material into a patient
US20030161823A1 (en) * 1998-08-31 2003-08-28 Neta Ilan Therapeutic and cosmetic uses of heparanases
US6177545B1 (en) * 1997-09-02 2001-01-23 Insight Strategy & Marketing Ltd. Heparanase specific molecular probes and their use in research and medical applications
US20040213789A1 (en) * 1997-09-02 2004-10-28 Oron Yacoby-Zeevi Heparanase activity neutralizing anti-heparanase monoclonal antibody and other anti-heparanase antibodies
US6562950B2 (en) * 1997-09-02 2003-05-13 Insight Strategy & Marketing Ltd. Heparanase activity neutralizing anti-heparanase monoclonal antibody
US20020088019A1 (en) * 1997-09-02 2002-07-04 Oron Yacoby-Zeevi Methods of and pharmaceutical compositions for improving implantation of embryos
US6699672B1 (en) 1997-09-02 2004-03-02 Insight Biopharmaceuticals Ltd. Heparanase specific molecular probes and their use research and medical applications
US20030217375A1 (en) * 1998-08-31 2003-11-20 Eyal Zcharia Transgenic animals expressing heparanase and uses thereof
AU2878600A (en) * 1999-03-01 2000-09-21 Hadasit Medical Research Services & Development Company Ltd Polynucleotide encoding a polypeptide having heparanase activity and expression of same in genetically modified cells
GB9913415D0 (en) * 1999-06-10 1999-08-11 Central Manchester Healthcare Heparanase assay
CA2286414A1 (en) * 1999-10-04 2001-04-04 Zhibo Gan Non-separation heterogenous assay for biological substance
WO2002023197A2 (en) 2000-09-15 2002-03-21 Reddy Us Therapeutics, Inc. Methods and compositions for glycosidase assays
CA2446962A1 (en) * 2001-05-09 2002-11-14 Insight Biopharmaceuticals Ltd. Methods and kits utilizing heparanase as a diagnostic marker for haemostatic disorders
US6671189B2 (en) * 2001-11-09 2003-12-30 Minebea Co., Ltd. Power converter having primary and secondary side switches
DE10258770B4 (de) * 2001-12-18 2005-02-10 F. Hoffmann-La Roche Ag Verfahren zum Testen eines Mittels auf dessen Fähigkeit, die Heparanaseaktivität zu hemmen
CH696701A5 (de) * 2001-12-18 2007-10-15 Hoffmann La Roche Verfahren zum Testen eines Mittels auf dessen Fähigkeit, die Heparanaseaktivität zu hemmen.
US7632654B2 (en) * 2002-04-29 2009-12-15 Academisch Ziekenhuis Bij De Universiteit Van Amsterdam Means and methods for detecting endoglycosidase activity
FR2843126B1 (fr) 2002-08-01 2006-01-27 Cis Bio Int "methode de determination d'une activite enzymatique endoglycosidase"
WO2004108065A2 (en) * 2003-06-09 2004-12-16 Insight Biopharmaceuticals Ltd. Heparanase activity neutralizing anti- heparanase monoclonal antibody and other anti-heparanase antibodies
WO2005040163A1 (en) * 2003-10-28 2005-05-06 Dr. Reddy's Laboratories Ltd Heterocyclic compounds that block the effects of advanced glycation end products (age)
US7521226B2 (en) * 2004-06-30 2009-04-21 Kimberly-Clark Worldwide, Inc. One-step enzymatic and amine detection technique
US7906276B2 (en) * 2004-06-30 2011-03-15 Kimberly-Clark Worldwide, Inc. Enzymatic detection techniques
US7094528B2 (en) 2004-06-30 2006-08-22 Kimberly-Clark Worldwide, Inc. Magnetic enzyme detection techniques
US7504235B2 (en) * 2005-08-31 2009-03-17 Kimberly-Clark Worldwide, Inc. Enzyme detection technique
US8758989B2 (en) * 2006-04-06 2014-06-24 Kimberly-Clark Worldwide, Inc. Enzymatic detection techniques
US7897360B2 (en) 2006-12-15 2011-03-01 Kimberly-Clark Worldwide, Inc. Enzyme detection techniques
US7977102B2 (en) * 2007-06-15 2011-07-12 Los Alamos National Security, Llc Isotopically labeled compositions and method
EP2333555A1 (de) * 2009-12-09 2011-06-15 Siemens Healthcare Diagnostics Products GmbH Heterogener Gerinnungstest
GB201305986D0 (en) * 2013-04-03 2013-05-15 Asociaci N Ct De Investigaci N Cooperativa En Biomateriales Synthesis and use of isotopically-labelled glycans
ES2564426B2 (es) * 2014-09-19 2016-09-12 Universidad De Oviedo Marcador de patologías oculares
EP3252082A1 (en) * 2016-05-31 2017-12-06 Galderma S.A. Method for deacetylation of biopolymers
KR20180121492A (ko) * 2015-12-29 2018-11-07 갈데르마 소시에떼아노님 아미드 결합의 절단 방법
EP3252080A1 (en) * 2016-05-31 2017-12-06 Galderma S.A. Method for preparing acylated crosslinked glycosaminoglycans
PT3623390T (pt) 2016-05-31 2023-10-27 Galderma Sa Reticulador de hidrato de carbono
WO2018067449A1 (en) 2016-10-05 2018-04-12 Bio-Techne Corporation Methods and kits for assaying endoglycosidase activity
WO2021111303A1 (en) 2019-12-02 2021-06-10 Galderma Holding SA High molecular weight esthetic compositions
CA3165060C (en) 2020-01-21 2023-06-20 Yiming Zhao Deglycosylation methods for electrophoresis of glycosylated proteins

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE336915B (fi) * 1968-01-15 1971-07-19 Pharmacia Ab
JPS6040859B2 (ja) * 1977-07-27 1985-09-12 喜温 三浦 抗血栓性人工医療材料
US4302536A (en) * 1978-08-15 1981-11-24 Longenecker Robert W Colorimetric immunoassay process
US4239664A (en) * 1978-10-31 1980-12-16 Research Corporation Anti-thrombogenic PVP-heparin polymer
US4281061A (en) * 1979-07-27 1981-07-28 Syva Company Double antibody for enhanced sensitivity in immunoassay
US4385046A (en) * 1980-12-15 1983-05-24 Minnesota Mining And Manufacturing Company Diagnostic radio-labeled polysaccharide derivatives
DE98814T1 (de) * 1982-06-10 1984-06-20 Kabivitrum Ab, 11287 Stockholm Antithrombin-heparin komplex.
US4677058A (en) * 1983-05-19 1987-06-30 Karl Tryggvason Detecting malignant cells with monoclonal antibodies specific to type IV collagenase enzyme
DE3519011A1 (de) * 1985-05-25 1986-11-27 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung eines materials zur affinitaetschromatographie

Also Published As

Publication number Publication date
NO870977L (no) 1987-09-11
US5332812A (en) 1994-07-26
AU609386B2 (en) 1991-05-02
AU6987087A (en) 1987-09-17
DK122087D0 (da) 1987-03-10
NO870977D0 (no) 1987-03-10
DK122087A (da) 1987-12-04
EP0244932A3 (en) 1991-05-22
US4859581A (en) 1989-08-22
EP0244932A2 (en) 1987-11-11
FI871039A (fi) 1987-09-11

Similar Documents

Publication Publication Date Title
FI871039A (fi) Foerfarande foer bestaemmande av endoglykosidasaktivitet.
FI874616A (fi) Anordning foer reglering av foerbraennings-luft-foerhaollandet.
FI871663A (fi) Oeverfoeringsfoerfarande av uppdateringsinformation foer en stationaer videobild.
FI875342A0 (fi) Foerfarande foer mekanisk-termisk avvattning av en fibermaterialbana.
FI875481A (fi) Foerfarande foer framstaellning av kristallina vinylaromatiska polymerer.
FI871230A0 (fi) Maskinbeklaednad foer arkformningsdelen av en pappersmaskin.
FI77063B (fi) Foerfarande foer effektivering av fibersuspensionstvaett.
FI874236A0 (fi) Redskap foer stoedande av koerbanor avsedda foer roerliga leksaker.
FI871313A0 (fi) Foerfarande foer framstaellning av laekemedelsadsorbat.
FI875315A0 (fi) Foerfarande foer framstaellning av 2 -substituerade metylpenicillinderivat.
FI874063A (fi) Foerfarande foer framstaellning av bensoesyraderivat.
FI873654A0 (fi) Maetning av arkmaterial innehaollande fuktskikt.
FI865039A (fi) Foerpackning av slipmaterial.
FI875488A0 (fi) Foerfarande foer soenderdelning av akrylamid.
FI870738A (fi) Inloppslaoda foer framstaellning av fiberaemnesbanor.
FI873441A0 (fi) Reversibel fasfoeraendringskomposition av hydraterad kalciumbromid.
FI871516A0 (fi) Anordning foer skoerning av fanerskivor.
FI860245A (fi) Foerfarande foer identifiering av en traeytas ytegenskaper.
FI872125A0 (fi) Anordning foer skrapning av skinn.
FI875058A0 (fi) Anordning foer loesgoerbart faestande av en skidsko.
FI870675A0 (fi) Framstaellning av cyanidhydratas.
FI860623A (fi) Foerfarande foer framstaellning av fiskfoderpellets.
FI871862A (fi) Foerflyttning av glasskivor foer bombering daerav.
FI870087A0 (fi) Bestraolningsanordning av solenergi foer medicinskt bruk.
FI890810A (fi) Behandling av braennskador.

Legal Events

Date Code Title Description
FD Application lapsed
FD Application lapsed

Owner name: BOARD OF REGENTS